Rivus Pharmaceuticals CEO Allen Cunningham (L) and CSO Shaharyar Khan
Weight loss player gets attention of RA Capital, walks away with $132M to keep pursuing big targets
A biotech out to corner a new market in the diabetes and weight loss space has recorded its second, and so far largest, raise yet …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
